XML 35 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 10. Discontinued Operations
9 Months Ended
Mar. 31, 2014
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Discontinued Operations
Discontinued Operations

BH Holdings, S.A.S

On January 12, 2012 BHH initiated the filing of an insolvency declaration with the Tribunal de Commerce de Rennes, France ("Commercial Court").  The Commercial Court on January 18, 2012 opened the liquidation proceedings with continuation of BHH's activity for three months and named an administrator to manage BHH. Since Drew no longer had a controlling financial interest in BHH it was deconsolidated in the December 31, 2011 quarterly condensed consolidated financial statements and prior period amounts were presented as discontinued operations.
The following tables summarize the results of discontinued operations of BHH for the three-month and nine-month periods ended March 31, 2014 and 2013 (in thousands):

 
 
 
 
For the three months ended March 31,
2014
 
2013
Revenue, net
$

 
$

Cost of goods sold

 

Marketing, general and administrative
25

 

Research & development

 

Total Costs and expenses
25

 

Loss from discontinued operations
$
(25
)
 
$


 
 
 
 
 
 
 
 
For the nine months ended March 31,
2014
 
2013
Revenue, net
$

 
$

Cost of goods sold

 

Marketing, general and administrative
75

 

Research & development

 

Total Costs and expenses
75

 

 
 
 
 
Loss from discontinued operations
$
(75
)
 
$

    
Assets and liabilities of discontinued operations of BHH included in the condensed consolidated balance sheets are summarized as follows at March 31, 2014 and June 30, 2013 (in thousands):
 
March 31,
 
June 30,
 
2014
 
2013
Total assets
$

 
$

Liabilities
 
 
 
Accrued lease termination costs
568

 
493

Total liabilities
568

 
493

Net liabilities of discontinued operations
$
(568
)
 
$
(493
)
Discontinued operation of ECD
On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The ECD consisted of Drew Scientific, Inc., and its wholly owned subsidiaries JAS and Drew Scientific Limited Co. The sales price was $6,500,000 in cash and gain on sale of assets was approximately $2,717,000. The following table is in thousands:
 
October 3, 2012
Sales Price
$
6,500

Broker's fee
325

Net Proceeds
6,175

Net Assets Sold
(3,458
)
Gain on Sale of Assets
$
2,717

 
 
Net assets sold
 
Assets:
 
  Cash and cash equivalents
$
4

  Accounts receivable, net
1,661

  Inventory, net
1,997

  Other current assets
113

Furniture and equipment, net
287

Goodwill
93

Trademarks and trade names, net
89

Customer list, net
462

Total Assets
4,706

 


Liabilities:
 
Accounts payable
639

Accrued expenses
609

Total liabilities
1,248

Net assets sold
$
3,458


On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid the balance of the seller-provided financing plus accrued interest related to the purchase of certain assets of Biocode of $4,367,604 with a one-time payment of $2,487,480 resulting in a gain on extinguishment of debt of $1,880,124. The repayment of the debt has reduced the Company's debt related to Biocode to zero.
The following tables summarize the results of discontinued operations for the three-month and nine-month periods ended March 31, 2014 and 2013 (in thousands):
 
 
 
 
 
For the three months ended March 31,
2014
 
2013
Revenue, net
$

 
$

Cost of goods sold

 

Marketing, general and administrative
1

 
1

Research & development

 

Total costs and expenses
1

 
1

Other expense

 

Net (loss) from discontinued operations
(1
)
 
(1
)
Gain from sale of assets and debt settlement net of tax (CTA included)

 
(1
)
Net (loss) income from discontinued operations, net of tax
$
(1
)
 
$
(2
)

For the nine months ended March 31,
2014
 
2013
Revenue, net
$

 
$
3,637

Cost of goods sold


 
2,194

Marketing, general and administrative
3

 
1,249

Research & development

 
76

Total costs and expenses
3

 
3,519

Net (loss) income from discontinued operations
(3
)
 
118

Gain from sale of assets and debt settlement, net of tax (CTA included)

 
3,938

Net loss (income)
$
(3
)
 
$
4,056


Assets and liabilities of discontinued operations of ECD included in the condensed consolidated balance sheets are summarized as follows at March 31, 2014 and June 30, 2013 (in thousands):
 
March 31,
 
June 30,
 
2014
 
2013
Total Assets
$

 
$

Liabilities
 
 
 
Accrued expenses
55

 
80

Total liabilities
55

 
80

Net liabilities of discontinued operations
$
(55
)
 
$
(80
)
BH Holdings, S.A.S [Member]
 
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Schedule of Discontinued Operations
BH Holdings, S.A.S

On January 12, 2012 BHH initiated the filing of an insolvency declaration with the Tribunal de Commerce de Rennes, France ("Commercial Court").  The Commercial Court on January 18, 2012 opened the liquidation proceedings with continuation of BHH's activity for three months and named an administrator to manage BHH. Since Drew no longer had a controlling financial interest in BHH it was deconsolidated in the December 31, 2011 quarterly condensed consolidated financial statements and prior period amounts were presented as discontinued operations.
The following tables summarize the results of discontinued operations of BHH for the three-month and nine-month periods ended March 31, 2014 and 2013 (in thousands):

 
 
 
 
For the three months ended March 31,
2014
 
2013
Revenue, net
$

 
$

Cost of goods sold

 

Marketing, general and administrative
25

 

Research & development

 

Total Costs and expenses
25

 

Loss from discontinued operations
$
(25
)
 
$


 
 
 
 
 
 
 
 
For the nine months ended March 31,
2014
 
2013
Revenue, net
$

 
$

Cost of goods sold

 

Marketing, general and administrative
75

 

Research & development

 

Total Costs and expenses
75

 

 
 
 
 
Loss from discontinued operations
$
(75
)
 
$

    
Assets and liabilities of discontinued operations of BHH included in the condensed consolidated balance sheets are summarized as follows at March 31, 2014 and June 30, 2013 (in thousands):
 
March 31,
 
June 30,
 
2014
 
2013
Total assets
$

 
$

Liabilities
 
 
 
Accrued lease termination costs
568

 
493

Total liabilities
568

 
493

Net liabilities of discontinued operations
$
(568
)
 
$
(493
)
ECD [Member]
 
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]  
Schedule of Discontinued Operations
On October 3, 2012 the Company sold its Clinical Diagnostics Business to ERBA Diagnostics, Inc. The ECD consisted of Drew Scientific, Inc., and its wholly owned subsidiaries JAS and Drew Scientific Limited Co. The sales price was $6,500,000 in cash and gain on sale of assets was approximately $2,717,000. The following table is in thousands:
 
October 3, 2012
Sales Price
$
6,500

Broker's fee
325

Net Proceeds
6,175

Net Assets Sold
(3,458
)
Gain on Sale of Assets
$
2,717

 
 
Net assets sold
 
Assets:
 
  Cash and cash equivalents
$
4

  Accounts receivable, net
1,661

  Inventory, net
1,997

  Other current assets
113

Furniture and equipment, net
287

Goodwill
93

Trademarks and trade names, net
89

Customer list, net
462

Total Assets
4,706

 


Liabilities:
 
Accounts payable
639

Accrued expenses
609

Total liabilities
1,248

Net assets sold
$
3,458


On October 18, 2012, the Company and its debt holder reached an agreement whereby the Company paid the balance of the seller-provided financing plus accrued interest related to the purchase of certain assets of Biocode of $4,367,604 with a one-time payment of $2,487,480 resulting in a gain on extinguishment of debt of $1,880,124. The repayment of the debt has reduced the Company's debt related to Biocode to zero.
The following tables summarize the results of discontinued operations for the three-month and nine-month periods ended March 31, 2014 and 2013 (in thousands):
 
 
 
 
 
For the three months ended March 31,
2014
 
2013
Revenue, net
$

 
$

Cost of goods sold

 

Marketing, general and administrative
1

 
1

Research & development

 

Total costs and expenses
1

 
1

Other expense

 

Net (loss) from discontinued operations
(1
)
 
(1
)
Gain from sale of assets and debt settlement net of tax (CTA included)

 
(1
)
Net (loss) income from discontinued operations, net of tax
$
(1
)
 
$
(2
)

For the nine months ended March 31,
2014
 
2013
Revenue, net
$

 
$
3,637

Cost of goods sold


 
2,194

Marketing, general and administrative
3

 
1,249

Research & development

 
76

Total costs and expenses
3

 
3,519

Net (loss) income from discontinued operations
(3
)
 
118

Gain from sale of assets and debt settlement, net of tax (CTA included)

 
3,938

Net loss (income)
$
(3
)
 
$
4,056


Assets and liabilities of discontinued operations of ECD included in the condensed consolidated balance sheets are summarized as follows at March 31, 2014 and June 30, 2013 (in thousands):
 
March 31,
 
June 30,
 
2014
 
2013
Total Assets
$

 
$

Liabilities
 
 
 
Accrued expenses
55

 
80

Total liabilities
55

 
80

Net liabilities of discontinued operations
$
(55
)
 
$
(80
)